Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Kenneth Lee

Thoracic Surgery (Cardiothoracic Vascular Surgery) Jupiter, FL Medical Doctor

NPI 1295734960 CMS profile 12925

1240 S Old Dixie Hwy, Jupiter, FL 33458

Open in the dashboard

General payments

$95,837

215 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$20,989 paid to institutions, not to them · program years 2020–2024

Through program year 2025, Kenneth Lee of Jupiter, FL is reported in the CMS Open Payments database as having received $95,837 across 215 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $20,989 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 93rd percentile of Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $15,532 34
2024 General $24,377 43
2023 General $12,177 26
2022 General $3,730 14
2021 General $7,263 23
2020 General $15,064 30
2019 General $17,695 45

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Kenneth Lee
  • Thoracic Surgery (Cardiothoracic Vascular Surgery) median
  • Middle half of Thoracic Surgery (Cardiothoracic Vascular Surgery)
  • National median

In program year 2025, general payments to Kenneth Lee were reported at $15,532. Among 4,073 Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles paid that year, the median was $791 and the middle half received between $208 and $3,074.

Show as a table
Year Kenneth Lee Thoracic Surgery (Cardiothoracic Vascular Surgery) median Middle half National median
2019 $17,695 $886 $178–$3,167 $163
2020 $15,064 $341 $108–$1,605 $114
2021 $7,263 $453 $125–$1,886 $132
2022 $3,730 $695 $180–$2,566 $149
2023 $12,177 $745 $205–$2,662 $160
2024 $24,377 $799 $214–$2,967 $164
2025 $15,532 $791 $208–$3,074 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AstraZeneca Pharmaceuticals LP $39,872 80 payments
  2. Intuitive Surgical, Inc. $17,483 32 payments
  3. Elucent Medical $13,778 9 payments
  4. Baxter Healthcare $12,297 13 payments
  5. Veran Medical Technologies, Inc. $7,510 11 payments
  6. Pulmonx Corporation $1,278 5 payments
  7. Medtronic, Inc. $971 10 payments
  8. FUJIFILM Medical Systems USA, Inc. $366 4 payments
  9. Ethicon US, LLC $305 3 payments
  10. Galvanize Therapeutics, Inc $297 2 payments
  11. Other $1,681 46 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $40,125 26 payments
  2. Consulting Fee $18,939 8 payments
  3. Food and Beverage $11,193 149 payments
  4. Education $11,158 2 payments
  5. Travel and Lodging $8,326 26 payments
  6. Honoraria $5,900 2 payments
  7. Gift $197 2 payments
Products named General payments · program years 2019–2025
  1. TAGRISSO $20,657 50 payments
  2. Da Vinci Surgical System $17,367 31 payments
  3. COSEAL $8,361 5 payments
  4. HEMOPATCH $8,323 4 payments
  5. Spin $7,510 11 payments
  6. IMFINZI Cardiovascular And Metabolism $6,567 6 payments
  7. PERI-STRIPS DRY $3,618 3 payments
  8. IMFINZI Oncology $2,805 7 payments
  9. Pulmonx Endobronchial Valve EBV $1,278 5 payments
  10. Signia $432 6 payments
  11. Other $3,294 66 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

62

Median for Thoracic Surgery: 42

Drug cost

$558

Median for Thoracic Surgery: $318

Branded share of claims

100%

Median for Thoracic Surgery: 0%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 62 $558

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 910 Part D prescribers listed as Thoracic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 34 billing codes

Paid by Medicare

$95,328

Medicare's payments for the services billed

Medicare patients

305

Average age 77

Services billed

507

173 women, 132 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Cancer 62%
Ischemic heart disease 50%
Arthritis 50%
COPD 49%
Atrial fibrillation 28%
Diabetes 25%
Chronic kidney disease 24%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

2 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
TAGRISSO
  • AstraZeneca Pharmaceuticals LP $5,114
$5,114 — —
KEYTRUDA
  • Merck Sharp & Dohme Corporation $18
$18 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

215 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Thoracic Surgery (Cardiothoracic Vascular Surgery) in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record